Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.47 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDR | P35968 | 2/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | BLVRB | P30043 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.46 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.46 |
| ▸ | DNMT3L | Q9UJW3 | 1/20 | 0.46 |
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11049685 | 0.87 | ALDH1A1 (0.50) | GAATSHRSLC5A1SLC5A2MEN1 | |
| SCHEMBL5390124 | 0.87 | GAA (0.53) | GAATSHRSLC5A1SLC5A2MEN1 | |
| SCHEMBL9739884 | 0.86 | MAOB (0.56) | GAASLC5A1SLC5A2MEN1KMT2A | |
| SCHEMBL18614861 | 0.84 | GAA (0.70) | GAATSHRMEN1KMT2ACA1 | |
| SCHEMBL5466042 | 0.83 | CA12 (0.53) | GAATSHRSLC5A1SLC5A2CA1 | |
| SCHEMBL9192183 | 0.83 | CA12 (0.47) | GAATSHRSLC5A1SLC5A2MCL1 | |
| SCHEMBL18311223 | 0.83 | KAT6A (0.59) | GAATSHRMEN1KMT2ACA1 | |
| SCHEMBL9678178 | 0.82 | KDM4E (0.45) | GAATSHRSLC5A1SLC5A2MCL1 | |
| SCHEMBL19745151 | 0.81 | GAA (0.50) | GAATSHRSLC5A1SLC5A2MEN1 | |
| SCHEMBL1607883 | 0.79 | GAA (0.49) | GAATSHRMCL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079989-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| US-9079989-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20150025213-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20150025213-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2015-01-22 | — | — | US | disclosed |
| US-8883946-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8883946-B2 | Charge control resin and manufacturing method of the same | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20140080989-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-03-20 | — | — | US | disclosed |
| US-20140080989-A1 | CHARGE CONTROL RESIN AND MANUFACTURING METHOD OF THE SAME | ORIENT CHEMICAL INDUSTRIES CO., LTD. (JP) | 2014-03-20 | — | — | US | disclosed |
| WO-2012157713-A1 | CHARGE CONTROL RESIN AND METHOD FOR MANUFACTURING CHARGE CONTROL RESIN | オリヱント化学工業株式会社 (JP) | 2012-11-22 | — | — | WO | disclosed |
| US-7378552-B2 | Monoamine re-uptake inhibitors and methods relating thereto | NEUROCRINE BIOSCIENCES, INC. (US) | 2008-05-27 | — | — | US | disclosed |
| US-20070161631-A1 | Substituted Phenoxyacetic Acids | PHARMACIA & UPJOHN COMPANY | 2007-07-12 | — | — | US | disclosed |
| US-7189749-B2 | Substituted phenoxyacetic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189749-B2 | Substituted phenoxyacetic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189749-B2 | Substituted phenoxyacetic acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-20050239849-A1 | Useful for therapy of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor | THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. (US) | 2005-10-27 | — | — | US | disclosed |
| US-20030036558-A1 | Substituted phenoxyacetic acids | THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. | 2003-02-20 | — | — | US | disclosed |
| CN-1364153-A | Substituted phenoxyacetic acids | INST PHARMACEUTICAL DISCOVERY (US) | 2002-08-14 | — | — | CN | disclosed |
| US-6420426-B1 | USED TO TREAT COMPLICATIONS FROM DIABETES MELLITUS | THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC | 2002-07-16 | — | — | US | disclosed |
| EP-1198451-A2 | SUBSTITUTED PHENOXYACETIC ACIDS | The Institutes for Pharmaceutical Discovery, LLC (US) | 2002-04-24 | — | — | EP | disclosed |
| WO-2001000566-A2 | SUBSTITUTED PHENOXYACETIC ACIDS | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) | 2001-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161631-A1 | Substituted Phenoxyacetic Acids | SLC5A2, GPR119, SLC5A1 | GAA 48/4885TSHR 1343/4885SLC5A1 3/4885 |
| US-20050239849-A1 | Useful for therapy of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor | ACE, DNPEP, AGT | GAA 79/4885TSHR 3762/4885SLC5A1 29/4885 |
| US-20030036558-A1 | Substituted phenoxyacetic acids | SLC5A2, GPR119, SLC5A1 | GAA 48/4885TSHR 1343/4885SLC5A1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.